171 related articles for article (PubMed ID: 16918996)
1. Prediction of carcinogenic potential by a toxicogenomic approach using rat hepatoma cells.
Tsujimura K; Asamoto M; Suzuki S; Hokaiwado N; Ogawa K; Shirai T
Cancer Sci; 2006 Oct; 97(10):1002-10. PubMed ID: 16918996
[TBL] [Abstract][Full Text] [Related]
2. CARCINOscreen®: New short-term prediction method for hepatocarcinogenicity of chemicals based on hepatic transcript profiling in rats.
Matsumoto H; Saito F; Takeyoshi M
J Toxicol Sci; 2014; 39(5):725-34. PubMed ID: 25242402
[TBL] [Abstract][Full Text] [Related]
3. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database.
Uehara T; Minowa Y; Morikawa Y; Kondo C; Maruyama T; Kato I; Nakatsu N; Igarashi Y; Ono A; Hayashi H; Mitsumori K; Yamada H; Ohno Y; Urushidani T
Toxicol Appl Pharmacol; 2011 Sep; 255(3):297-306. PubMed ID: 21784091
[TBL] [Abstract][Full Text] [Related]
4. A toxicogenomic approach for the prediction of murine hepatocarcinogenesis using ensemble feature selection.
Eichner J; Kossler N; Wrzodek C; Kalkuhl A; Bach Toft D; Ostenfeldt N; Richard V; Zell A
PLoS One; 2013; 8(9):e73938. PubMed ID: 24040119
[TBL] [Abstract][Full Text] [Related]
5. Application of genomic biomarkers to predict increased lung tumor incidence in 2-year rodent cancer bioassays.
Thomas RS; Pluta L; Yang L; Halsey TA
Toxicol Sci; 2007 May; 97(1):55-64. PubMed ID: 17311802
[TBL] [Abstract][Full Text] [Related]
6. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
[TBL] [Abstract][Full Text] [Related]
7. Alternative Carcinogenicity Screening Assay Using Colon Cancer Stem Cells: A Quantitative PCR (qPCR)-Based Prediction System for Colon Carcinogenesis.
Bak Y; Jang HJ; Shin JW; Kim SJ; Chun HW; Seo JH; No SH; Chae JI; Son DH; Lee SY; Hong J; Yoon DY
J Microbiol Biotechnol; 2018 Apr; 28(4):645-651. PubMed ID: 29539880
[TBL] [Abstract][Full Text] [Related]
8. Assessing compound carcinogenicity in vitro using connectivity mapping.
Caiment F; Tsamou M; Jennen D; Kleinjans J
Carcinogenesis; 2014 Jan; 35(1):201-7. PubMed ID: 23940306
[TBL] [Abstract][Full Text] [Related]
9. Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action.
Gusenleitner D; Auerbach SS; Melia T; Gómez HF; Sherr DH; Monti S
PLoS One; 2014; 9(7):e102579. PubMed ID: 25058030
[TBL] [Abstract][Full Text] [Related]
10. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecular signatures predicting the carcinogenicity of polycyclic aromatic hydrocarbons (PAHs).
Song MK; Song M; Choi HS; Kim YJ; Park YK; Ryu JC
Toxicol Lett; 2012 Jul; 212(1):18-28. PubMed ID: 22579512
[TBL] [Abstract][Full Text] [Related]
12. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies.
Ellinger-Ziegelbauer H; Gmuender H; Bandenburg A; Ahr HJ
Mutat Res; 2008 Jan; 637(1-2):23-39. PubMed ID: 17689568
[TBL] [Abstract][Full Text] [Related]
13. Toxicogenomics discrimination of potential hepatocarcinogenicity of non-genotoxic compounds in rat liver.
Yamada F; Sumida K; Uehara T; Morikawa Y; Yamada H; Urushidani T; Ohno Y
J Appl Toxicol; 2013 Nov; 33(11):1284-93. PubMed ID: 22806939
[TBL] [Abstract][Full Text] [Related]
14. An improved model of predicting hepatocarcinogenic potential in rats by using gene expression data.
Yamada F; Sumida K; Saito K
J Appl Toxicol; 2016 Feb; 36(2):296-308. PubMed ID: 26198598
[TBL] [Abstract][Full Text] [Related]
15. Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning.
Auerbach SS; Shah RR; Mav D; Smith CS; Walker NJ; Vallant MK; Boorman GA; Irwin RD
Toxicol Appl Pharmacol; 2010 Mar; 243(3):300-14. PubMed ID: 20004213
[TBL] [Abstract][Full Text] [Related]
16. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
17. A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays.
Thomas RS; O'Connell TM; Pluta L; Wolfinger RD; Yang L; Page TJ
Toxicol Sci; 2007 Mar; 96(1):40-6. PubMed ID: 17114358
[TBL] [Abstract][Full Text] [Related]
18. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals.
Ito N; Tamano S; Shirai T
Cancer Sci; 2003 Jan; 94(1):3-8. PubMed ID: 12708466
[TBL] [Abstract][Full Text] [Related]
19. Prediction of rodent carcinogenesis: an evaluation of prechronic liver lesions as forecasters of liver tumors in NTP carcinogenicity studies.
Allen DG; Pearse G; Haseman JK; Maronpot RR
Toxicol Pathol; 2004; 32(4):393-401. PubMed ID: 15307212
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of toxicogenomics approaches for assessing the risk of nongenotoxic carcinogenicity in rat liver.
Eichner J; Wrzodek C; Römer M; Ellinger-Ziegelbauer H; Zell A
PLoS One; 2014; 9(5):e97678. PubMed ID: 24828355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
